| Literature DB >> 30190103 |
Ashish Sharma1, Mohd Saqib2, Javaid A Sheikh3, Nasreen Z Ehtesham3, Sangeeta Bhaskar2, Tapan K Chaudhuri4, Seyed E Hasnain5.
Abstract
Utility of Mycobacterium indicus pranii (MIP) as a multistage vaccine against mycobacterial infections demands identification of its protective antigens. We explored antigenicity and immunogenicity of a candidate protein MIP_05962 that depicts homology to HSP18 of M. leprae and antigen1 of Mycobacterium tuberculosis. This protein elicited substantial antibody response in immunized mice along with modulation of cellular immune response towards protective Th1 type. Both CD4+ and CD8+ subsets from immunized mice produced hallmark protective cytokines, IFN-γ, TNF-α and IL-2. This protein also enhanced the CD4+ effector memory that could act as first line of defence during infections. These results point to MIP_05962 as a protective antigen that contributes, in conjunction with others, to the protective immunity of this live vaccine candidate.Entities:
Keywords: CD4(+)cells; CD8(+)cells; Immunomodulation; Mycobacterium indicus pranii; Small heat shock proteins; Th1 immune response; Tuberculosis
Mesh：
Substances：
Year: 2018 PMID： 30190103 DOI： 10.1016/j.ijmm.2018.08.008
Source DB: PubMed Journal: Int J Med Microbiol ISSN： 1438-4221 Impact factor: 3.473